Get notified when ENGN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Passive Foreign Investment Company (new) — PFIC status can trigger adverse U.S. tax consequences for U.S. investors, including potential current taxation on unrealized gains.
enGene files up to $100M at-the-market offering of common shares via Leerink Partners
Filed March 9, 2026 · ~1 min read
Key Changes
-
high
enGene may sell up to $100 million of common shares from time to time through Leerink Partners as sales agent.
The Offering verify on EDGAR → -
medium
Proceeds go to the company for general corporate purposes, including development and potential commercialization of detalimogene.
Use of Proceeds verify on EDGAR → -
high
New investors would experience immediate dilution of $3.89 per share based on 66,989,466 shares outstanding as of January 31, 2026.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
Partner
Trade ENGN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify